These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Eltrombopag for treatment of thrombocytopenia-associated disorders. Merli P; Strocchio L; Vinti L; Palumbo G; Locatelli F Expert Opin Pharmacother; 2015; 16(14):2243-56. PubMed ID: 26364898 [TBL] [Abstract][Full Text] [Related]
4. Eltrombopag: an oral thrombopoietin receptor agonist for the treatment of idiopathic thrombocytopenic purpura. Zhang Y; Kolesar JM Clin Ther; 2011 Nov; 33(11):1560-76. PubMed ID: 22054810 [TBL] [Abstract][Full Text] [Related]
5. Eltrombopag in chronic idiopathic thrombocytopenic purpura and HCV-related thrombocytopenia. Panzer S Drugs Today (Barc); 2009 Feb; 45(2):93-9. PubMed ID: 19343229 [TBL] [Abstract][Full Text] [Related]
6. Thrombopoietin-receptor agonists for primary immune thrombocytopenia. Imbach P; Crowther M N Engl J Med; 2011 Aug; 365(8):734-41. PubMed ID: 21864167 [No Abstract] [Full Text] [Related]
7. Phase 1 clinical study of eltrombopag, an oral, nonpeptide thrombopoietin receptor agonist. Jenkins JM; Williams D; Deng Y; Uhl J; Kitchen V; Collins D; Erickson-Miller CL Blood; 2007 Jun; 109(11):4739-41. PubMed ID: 17327409 [TBL] [Abstract][Full Text] [Related]
8. Eltrombopag (Promacta), a thrombopoietin receptor agonist for the treatment of thrombocytopenia: current and future considerations. Serebruany VL; Eisert C; Sabaeva E; Makarov L Am J Ther; 2010; 17(1):68-74. PubMed ID: 19451811 [TBL] [Abstract][Full Text] [Related]
9. Eltrombopag: a review of its use in treatment-refractory chronic primary immune thrombocytopenia. Garnock-Jones KP Drugs; 2011 Jul; 71(10):1333-53. PubMed ID: 21770480 [TBL] [Abstract][Full Text] [Related]
10. Eltrombopag: an update on the novel, non-peptide thrombopoietin receptor agonist for the treatment of immune thrombocytopenia. Kühne T; Imbach P Ann Hematol; 2010 Jul; 89 Suppl 1():67-74. PubMed ID: 20405290 [TBL] [Abstract][Full Text] [Related]
11. Molecule of the month. Eltrombopag. Drug News Perspect; 2008; 21(6):344. PubMed ID: 18836592 [No Abstract] [Full Text] [Related]
12. Dental procedures in 24 patients with chronic immune thrombocytopenia in prospective clinical studies of eltrombopag. Tarantino MD; Fogarty PF; Shah P; Brainsky A Platelets; 2015; 26(1):93-6. PubMed ID: 24433306 [TBL] [Abstract][Full Text] [Related]
13. Current treatment options for primary immune thrombocytopenia. Salama A Expert Rev Hematol; 2011 Feb; 4(1):107-18. PubMed ID: 21322783 [TBL] [Abstract][Full Text] [Related]
18. Successful treatment of severe thrombocytopenia with the use of thrombopoeitin receptor agonist eltrombopag in a patient with chronic myelomonocytic leukemia. Modi Y; Shaaban H; Gauchan D; Maroules M J Oncol Pharm Pract; 2015 Feb; 21(1):74-5. PubMed ID: 25063763 [TBL] [Abstract][Full Text] [Related]